# OnCo record glytr-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/glytr-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "glytr-therapeutics" ;
  schema:name "GlyTR Therapeutics"@en ;
  schema:alternateName "GlyTR Therapeutics, Inc."@en ;
  schema:description "GlyTR Therapeutics is developing immune treatments that recognise sugar molecules found in large amounts on many kinds of cancer cell, rather than a single protein. Its medicines are still in laboratory and animal testing."@en ;
  schema:url <https://onco.cc/companies/glytr-therapeutics/>, <https://glytrtherapeutics.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://glytrtherapeutics.com/>, <https://glytrtherapeutics.com/news/>, <https://reporter.nih.gov/project-details/11457445> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/>, <https://onco.cc/technologies/car-t/> ;
  onco:drugs <https://onco.cc/drugs/glytr1/> .